WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 525003

CAS#: 26927-01-5

Description: 7DG is a selective inhibitor of protein kinase R (PKR). 7DG appears to directly interact with the C-terminal half of PKR, and unlike C16, does not bind the ATP catalytic pocket. 7-Desacetoxy-6,7-dehydrogedunin completely protected macrophages from anthrax lethal toxin (LT)-induced pyroptotic cell death, a model for inflammasome-mediated caspase-1 activation, with an (IC50) of 5 μM, showing a role for PKR in pyroptosis.

Chemical Structure

CAS# 26927-01-5

Theoretical Analysis

MedKoo Cat#: 525003
Name: 7-DG
CAS#: 26927-01-5
Chemical Formula: C26H30O5
Exact Mass: 422.2093
Molecular Weight: 422.521
Elemental Analysis: C, 73.91; H, 7.16; O, 18.93

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: 7DG, 7-DG, 7 DG

IUPAC/Chemical Name: (1S,3aS,4aS,4bR,6aR,10aR,10bR,12aS)-1-(furan-3-yl)-4b,7,7,10a,12a-pentamethyl-1,6a,7,10a,10b,11,12,12a-octahydronaphtho[2,1-f]oxireno[2,3-d]isochromene-3,8(3aH,4bH)-dione


InChi Code: InChI=1S/C26H30O5/c1-22(2)16-6-11-24(4)17(23(16,3)10-8-18(22)27)7-12-25(5)19(15-9-13-29-14-15)30-21(28)20-26(24,25)31-20/h6,8-11,13-14,16-17,19-20H,7,12H2,1-5H3/t16-,17+,19-,20+,23-,24+,25-,26-/m0/s1

SMILES Code: CC1(C)C(C=C[C@@]2(C)[C@H]1C=C[C@]3(C)[C@@H]2CC[C@]4(C)[C@]3(O5)[C@H]5C(O[C@H]4C6=COC=C6)=O)=O

Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 422.521 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Maloney E, Hippe DS, Paladin A, Chew FS, Ha AS. Musculoskeletal Ultrasound Training for Radiology Residents: Lecture Versus Interactive Learning Module. Acad Radiol. 2016 Jul;23(7):789-96. doi: 10.1016/j.acra.2015.11.018. Epub 2016 Apr 8. PubMed PMID: 27067604.

2: Kawanishi M, Fujikawa Y, Ishii H, Nishida H, Higashigaki Y, Kanno T, Matsuda T, Takamura-Enya T, Yagi T. Adduct formation and repair, and translesion DNA synthesis across the adducts in human cells exposed to 3-nitrobenzanthrone. Mutat Res. 2013 May 15;753(2):93-100. doi: 10.1016/j.mrgentox.2013.03.005. Epub 2013 Apr 6. PubMed PMID: 23567330.

3: Moeller BC, Recio L, Green A, Sun W, Wright FA, Bodnar WM, Swenberg JA. Biomarkers of exposure and effect in human lymphoblastoid TK6 cells following [13C2]-acetaldehyde exposure. Toxicol Sci. 2013 May;133(1):1-12. doi: 10.1093/toxsci/kft029. Epub 2013 Feb 19. PubMed PMID: 23425604; PubMed Central PMCID: PMC3627555.

4: Lu K, Collins LB, Ru H, Bermudez E, Swenberg JA. Distribution of DNA adducts caused by inhaled formaldehyde is consistent with induction of nasal carcinoma but not leukemia. Toxicol Sci. 2010 Aug;116(2):441-51. doi: 10.1093/toxsci/kfq061. Epub 2010 Feb 22. PubMed PMID: 20176625; PubMed Central PMCID: PMC2905397.

5: Synold T, Xi B, Wuenschell GE, Tamae D, Figarola JL, Rahbar S, Termini J. Advanced glycation end products of DNA: quantification of N2-(1-Carboxyethyl)-2'-deoxyguanosine in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry. Chem Res Toxicol. 2008 Nov;21(11):2148-55. doi: 10.1021/tx800224y. PubMed PMID: 18808156; PubMed Central PMCID: PMC3253819.

6: Le Corre I, Delorme M, Cournoyer S. A prospective, randomized trial comparing a transparent dressing and a dry gauze on the exit site of long term central venous catheters of hemodialysis patients. J Vasc Access. 2003 Apr-Jun;4(2):56-61. PubMed PMID: 17642061.

7: Alekseyev YO, Hamm ML, Essigmann JM. Aflatoxin B1 formamidopyrimidine adducts are preferentially repaired by the nucleotide excision repair pathway in vivo. Carcinogenesis. 2004 Jun;25(6):1045-51. Epub 2004 Jan 23. PubMed PMID: 14742311.

8: Oba M, Allen MS. Effects of diet fermentability on efficiency of microbial nitrogen production in lactating dairy cows. J Dairy Sci. 2003 Jan;86(1):195-207. PubMed PMID: 12613865.

9: Doerge DR, Churchwell MI, Marques MM, Beland FA. Quantitative analysis of 4-aminobiphenyl-C8-deoxyguanosyl DNA adducts produced in vitro and in vivo using HPLC-ES-MS. Carcinogenesis. 1999 Jun;20(6):1055-61. PubMed PMID: 10357788.

10: Beland FA, Doerge DR, Churchwell MI, Poirier MC, Schoket B, Marques MM. Synthesis, characterization, and quantitation of a 4-aminobiphenyl-DNA adduct standard. Chem Res Toxicol. 1999 Jan;12(1):68-77. PubMed PMID: 9894020.

11: Alonso JC, Lüder G, Stiege AC, Chai S, Weise F, Trautner TA. The complete nucleotide sequence and functional organization of Bacillus subtilis bacteriophage SPP1. Gene. 1997 Dec 19;204(1-2):201-12. PubMed PMID: 9434185.

12: Benimetskaya L, Berton M, Kolbanovsky A, Benimetsky S, Stein CA. Formation of a G-tetrad and higher order structures correlates with biological activity of the RelA (NF-kappaB p65) 'antisense' oligodeoxynucleotide. Nucleic Acids Res. 1997 Jul 1;25(13):2648-56. PubMed PMID: 9185577; PubMed Central PMCID: PMC146791.

13: Kasagi K, Takeuchi R, Misaki T, Kousaka T, Miyamoto S, Iida Y, Konishi J. Subclinical Graves' disease as a cause of subnormal TSH levels in euthyroid subjects. J Endocrinol Invest. 1997 Apr;20(4):183-8. PubMed PMID: 9211123.

14: Lewis MA, Yoerg DG, Bolton JL, Thompson JA. Alkylation of 2'-deoxynucleosides and DNA by quinone methides derived from 2,6-di-tert-butyl-4-methylphenol. Chem Res Toxicol. 1996 Dec;9(8):1368-74. PubMed PMID: 8951242.

15: Shields PG, Kato S, Bowman ED, Petruzzelli S, Cooper DP, Povey AC, Weston A. Combined micropreparative techniques with synchronous fluorescence spectroscopy or 32P-postlabelling assay for carcinogen-DNA adduct determination. IARC Sci Publ. 1993;(124):243-54. PubMed PMID: 8225491.

16: Povey AC, Wilson VL, Weston A, Doan VT, Wood ML, Essigmann JM, Shields PG. Detection of oxidative damage by 32P-postlabelling: 8-hydroxydeoxyguanosine as a marker of exposure. IARC Sci Publ. 1993;(124):105-14. PubMed PMID: 8225472.

17: Prömpeler HJ, Wilhelm C, Madjar H, Wieacker P, Schillinger H. [Prognosis of triplet pregnancies]. Geburtshilfe Frauenheilkd. 1990 Sep;50(9):701-9. German. PubMed PMID: 2272436.

18: Krehan I. Die Steuerung von Jahresrhythmik und Diapause bei Larval-und Imagoüberwinterern der Gattung Pterostichus (Col., Carab.). Oecologia. 1970 Mar;6(1):58-105. doi: 10.1007/BF00345223. Review. German. PubMed PMID: 28309706.